OTC Markets:RHHBY
#Roche #receives #FDA #clearance #COVID19 #PCR #test The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated,...
Hi, what are you looking for?
#Roche #receives #FDA #clearance #COVID19 #PCR #test The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated,...
#Roche #present #OCREVUS #ocrelizumab #data #multiple OCREVUS data will show significant benefit on slowing disease activity and progression in patients with treatment-naive early-stage relapsing-remitting...
#hocMitteilung #gemäss #Art #Roche #mit #soliden Basel, 18. Oktober 2022 Konzernverkäufe steigen um 2%1 zu konstanten Wechselkursen (CER) und 1% in Schweizer Franken; wie...
#Positive #data #Roches #Evrysdi #largest #trial New two-year Evrysdi data show improvement or maintenance of motor function in people with SMA, a progressive neuromuscular...
#Roche #introduce #nextgeneration #portfolio Broad and trusted portfolio of COVID-19 rapid tests feature innovative updates and enhanced performance, building on insights gained throughout the...
#Roche #present #data #expanding #neuromuscular New positive data from Evrysdi, a treatment for spinal muscular atrophy (SMA), a progressive neuromuscular disease that can be...
#Roche #receives #FDA #approval #companion #diagnostic Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2. These patients with...